CARL FERGUSON: Open Payments
NPI 1619068681 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 11 payments from 6 companies in 2025. Trend: 2023 $343 · 2024 $720 · 2025 $369
Food & beverage: $369
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $223 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| Amgen Inc. | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 1 | $28 |
| Abbott Laboratories | 1 | $17 |
| Novo Nordisk Inc | 1 | $17 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, OTEZLA, VOQUEZNA, FARXIGA, PROCLAIM, Rybelsus.
Industry payments across AZ — which companies pay providers there.
